Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis

NCT00104741 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00104741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00104741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
September 10, 2003
Completion date
October 15, 2015
Enrollment
378 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer